Next, we knocked down hepatic TFEB (Fig. 9a) and subjected hepatic TFEB-deficient mice and controls to 1-week WD challenge, which aimed to determine if hepatic TFEB-deficient mice were more sensitive to WD-induced disturbance of cholesterol homeostasis. This evidence concerns the gene TFEB and Wilson disease.